Literature DB >> 23105632

Urinary N-acetyl beta glucosaminidase and gamma glutamyl transferase as early markers of diabetic nephropathy.

Vivek Ambade1, Parduman Sing, B L Somani, Dashrath Basanna.   

Abstract

Albumin and enzymes-N-acetyl-beta-glucosaminidase (NAG) and gamma glutamyl transferase (GGT) were estimated in the morning random urine samples of 196 albustix negative diabetic patients to evaluate the clinical utility of these urinary enzymes as early markers of diabetic nephropathy. Albumin was estimated by immunoturbidimetric method and enzymes by linetic essay within six hours of voiding of urine. The urinary albumin and urinary enzyme concentration was calculated in terms of ratio with respect to urinary creatinine. Correlation coefficient (r) bewween urinary albumin and urinary enzymes in normoalbuminuric, microalbuminuric and overall diabetic cases was 0.23, 0.32 and 0.40 respectively for NAG, and 0.08, 0.06 and 0.18 respectively for GGT. NAG excretion was found increased in 34%, 63.7% and 49.5% of normoalbuminuric, microalbuminuric and overall diabetic cases respectively while GGT in 6.4%, 24.5% and 15.8%. The correlation coefficient between urinary albumin and NAG in normoalbuminuric, microalbuminuric, and overall diabetic patients with increased NAG excretion was found only 0.31, 0.27 and 0.35 respectively. No correlation was found between duration of diabetes and enzyme excretion. The study suggests that urinary NAG or GGT or both together do not have any clinical significance as an early marker of diabetic nephropathy.

Entities:  

Keywords:  Diabetic nephropathy; Gamma glutamyl transferase; Microalbuminuria; N-acetyl-beta-glucosaminidase

Year:  2006        PMID: 23105632      PMCID: PMC3454003          DOI: 10.1007/BF02912930

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  24 in total

Review 1.  Microalbuminuria in essential hypertension and diabetes mellitus.

Authors:  H H Parving
Journal:  J Hypertens Suppl       Date:  1996-09

2.  Studies of human kidney gamma-glutamyl transpeptidase. Purification and structural, kinetic and immunological properties.

Authors:  S P Miller; Y C Awasthi; S K Srivastava
Journal:  J Biol Chem       Date:  1976-04-25       Impact factor: 5.157

3.  Clinical significance of urinary enzymes in diabetic nephropathy.

Authors:  E Morita; K Kaizu; K Uriu; O Hashimoto; N Komine; S Eto
Journal:  J Diabet Complications       Date:  1991 Apr-Sep

4.  [Clinical evaluation of urinary alanine aminopeptidase in the patients with diabetes mellitus-comparison among AAP microalbumin and N-acetyl-beta-D-glucosaminidase].

Authors:  S Nakamura
Journal:  Hokkaido Igaku Zasshi       Date:  1991-07

Review 5.  Diabetes, microalbuminuria and hypertension.

Authors:  J J Sheth
Journal:  Clin Exp Hypertens       Date:  1999 Jan-Feb       Impact factor: 1.749

Review 6.  [Antihypertensive therapy in diabetes mellitus].

Authors:  B Hess
Journal:  Ther Umsch       Date:  1999-01

7.  [Clinical evaluation of N-acetyl-beta-D-glucosaminidase on prediction of diabetic nephropathy].

Authors:  H Minakami
Journal:  Hokkaido Igaku Zasshi       Date:  1992-03

8.  Urinary N-acetyl-beta-D-glucosaminidase activity in type I diabetes mellitus.

Authors:  N Mungan; B Yuksel; M Bakman; A K Topaloglu; G Ozer
Journal:  Indian Pediatr       Date:  2003-05       Impact factor: 1.411

9.  Urinary excretion of N-acetyl-beta-D-glucosaminidase in children with type I diabetes mellitus.

Authors:  E N Ellis; B H Brouhard; L Lagrone; L B Travis
Journal:  Diabetes Care       Date:  1983 May-Jun       Impact factor: 19.112

Review 10.  [Diabetic nephropathy: significance of microalbuminuria and proteinuria in Type I and Type II diabetes mellitus].

Authors:  R Lehmann; G A Spinas
Journal:  Praxis (Bern 1994)       Date:  1995-10-31
View more
  8 in total

1.  Urinary N-acetyl-beta-d-glucosaminidase (NAG) with neutrophil gelatinase-associated lipocalin (NGAL) improves the diagnostic value for proximal tubule damage in diabetic kidney disease.

Authors:  Khalid Siddiqui; Basim Al-Malki; Teena Puthiyaparampil George; Shaik Sarfaraz Nawaz; Khalid Al Rubeaan
Journal:  3 Biotech       Date:  2019-02-04       Impact factor: 2.406

2.  Urinary biomarkers for early diabetic nephropathy in type 2 diabetic patients.

Authors:  Temesgen Fiseha
Journal:  Biomark Res       Date:  2015-07-04

3.  Urinary Lysosomal Enzyme Activities and Albuminuria in Ghanaian Patients with Type 2 Diabetes Mellitus.

Authors:  Henry Asare-Anane; Felix Twum; Emmanuel Kwaku Ofori; Erving L Torgbor; Seth D Amanquah; Charlotte Osafo
Journal:  Dis Markers       Date:  2016-08-09       Impact factor: 3.434

Review 4.  Urinary Biomarkers in the Assessment of Early Diabetic Nephropathy.

Authors:  Cristina Gluhovschi; Gheorghe Gluhovschi; Ligia Petrica; Romulus Timar; Silvia Velciov; Ioana Ionita; Adriana Kaycsa; Bogdan Timar
Journal:  J Diabetes Res       Date:  2016-06-16       Impact factor: 4.011

Review 5.  Potential Role of Serum and Urinary Biomarkers in Diagnosis and Prognosis of Diabetic Nephropathy.

Authors:  Carole G Campion; Oraly Sanchez-Ferras; Sri N Batchu
Journal:  Can J Kidney Health Dis       Date:  2017-05-22

Review 6.  Urinary Markers of Tubular Injury in Early Diabetic Nephropathy.

Authors:  Temesgen Fiseha; Zemenu Tamir
Journal:  Int J Nephrol       Date:  2016-05-16

Review 7.  The role of novel biomarkers in predicting diabetic nephropathy: a review.

Authors:  Samuel N Uwaezuoke
Journal:  Int J Nephrol Renovasc Dis       Date:  2017-08-17

8.  Evaluation of urinary biomarkers for prediction of diabetic kidney disease: a propensity score matching analysis.

Authors:  Yongzhang Qin; Shuang Zhang; Xiaofang Shen; Shunming Zhang; Jingyu Wang; Minxia Zuo; Xiao Cui; Zhongai Gao; Juhong Yang; Hong Zhu; Baocheng Chang
Journal:  Ther Adv Endocrinol Metab       Date:  2019-12-02       Impact factor: 3.565

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.